Clinical Trial Update: The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enteric-coated mycophenolate sodium (Myfortic) for relapse or resistant proliferative lupus nephritis was terminated; the snippet does …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Mycophenolate mofetil (Myfortic) (mycophenolate mofetil)

Snippet

Sponsor: Chulalongkorn University | Conditions: Lupus Nephritis | Phase 3 | Status: TERMINATED